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Abstract
OBJECTIVE: To study the effect of Lichong Decoc-
tion (Lichong Decoction for strengthening an-
ti-pathogenic Qi and eliminating blood stasis) on
the expression of insulin-like growth factor-I (IGF-I)
and proliferating cell nuclear antigen (PCNA) mRNA
in a rat model of uterine leiomyoma.
METHODS: Fifty female Wistar rats were random-
ized into a normal control group, model group, Li-
chong Decoction group, Guizhifuling Capsule (Cap-
sule containing Cassia Twig and Poria) group, and
Mifepristone group. The uterine leiomyoma model
was established by peritoneal injections of exoge-
nous estrogen and progesterone hormone. The ul-
trastructural changes in cells of rat uterine tissues
were observed with transmission electron micros-
copy, and the expression of IGF-I and PCNA mRNA
was detected by real-time fluorescent quantitative
PCR.
RESULTS: Following treatment, cells in the Lichong
Decoction group appeared to be arranged normal-
ly, the cellular morphology were almost in a normal
state, hyperplasia and hypertrophy of the chondrio-
some was reduced, collagen fibers were arranged
in a regular manner, without obvious hyperplasia,
and the expression of IGF-I and PCNA mRNA was
significantly decreased compared with the model
group (P<0.01).
CONCLUSIONS: The effect of Lichong Decoction
on uterine leiomyoma is related to its function in re-
ducing the expression of IGF-I and PCNAmRNA.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Uterine leiomyoma, which is a common disease of the
female reproductive system, has a great influence on
women's health and quality of life. Studies have shown
an association between uterine leiomyoma and exces-
sive proliferation of uterine smooth muscle cells.1,2 In
addition, the expression of insulin-like growth factor-I
(IGF-I) and proliferating cell nuclear antigen (PCNA)
has been shown to affect cell proliferation, thus the mo-
lecular basis of uterine leiomyoma development is relat-
ed to the overexpression of IGF-I andPCNA.3,4
Through the establishment of a rat model of uterine fi-
broids, using the real-time quantitative PCR tech-
nique, this study observed the effect of Lichong Decoc-
636
JTCM |www. journaltcm. com December 15, 2012 |volume 32 | Issue 4 |
Li DH et al. Lichong Decoction on IGF-I and proliferating cell nuclear antigen mRNA in uterine leiomyoma
tion, which has the function of strengthening an-
ti-pathogenic Qi and eliminating blood stasis, on the
expression of IGF-I and proliferating cell nuclear anti-
gen (PCNA) mRNA in a rat model of uterine leiomyo-
ma. The study also explored the molecular mechanisms
of this Chinese medicine in strengthening anti-patho-
genic Qi and eliminating blood stasis to inhibit uterine
fibroids for the purpose of providing a scientific experi-
mental basis for clinical treatment.
MATERIALS ANDMETHODS
Reagents and instruments
Fermentas K1622 RT-PCR Kit (ABI, USA); SYBR
Green PCR Master Mix (ABI, USA); TRIZOL reagent
(Invitrogen life technologies, USA); PRISM 5700 fluo-
rescent quantitative PCR (ABI, USA); DU-600 ultravi-
olet spectrophotometer (BECKMAN, USA); High
speed refrigerated centrifuge (BECKMAN, USA),
JEM-1230 transmission electron microscope (JEOL,
JAPAN).
Animals
Fifty healthy, non-pregnant, adult female Wistar rats,
weighing 220 ± 20 g, of SPF grade, were purchased
from the Academy of Military Medical Sciences, certi-
fied SCXK (Army) 2007-0004. Rats were bred in SPF
animal rooms of the Ministry of Experimental Ani-
mals, Capital Medical University, with normal light
conditions and free access to food and water, and were
housed at room temperature (18°C-22°C).
Drugs
Estradiol Benzoate Injection: Tianjin Jin Yao Amino
Acid Co., Ltd., Product batch number: 0703121, Spec-
ification: 1 mL:1 mg.
Progesterone Injection: Shanghai General Pharmaceuti-
cal Co., Ltd., Product batch number: 070902, Specifi-
cation: 1 mL:20 mg.
Lichong Decoction from the Yixue Zhong Zhong Can
Xi Lu (Records of Traditional Chinese and Western
Medicine in Combination) as was written by the fa-
mous doctor Xichun Zhang of Qing Dynasty. The
quantity of each medicine was converted from the orig-
inal to the following prescription: raw Huangqi (Radix
Astragali seu Hedysari) 9 g, Dangshen (Radix Co-
donopsis Pilosulae) 6 g, Baizhu (Rhizoma Atractylodis
Macrocephalae) 6 g, raw Shanyao (Rhizoma Dioscore-
ae) 15 g, Tianhuafen (Radix Trichosanthis) 12 g, Zhimu
(Rhizoma Anemarrhenae) 12 g, Sanleng (Rhizoma
Sparganii) 9 g, Ezhu (Rhizoma Zedoariae) 9 g, raw Jin-
eijin (Endothelium Corneum Gigeriae Galli) 9 g. The
Chinese medicines were purchased from Beijing Tong
Ren Tang Herbal Pieces Limited Liability Company.
The medicines were first processed by water extraction
twice, and then the preparation was concentrated to
3.30 g·mL-1. The daily dose for one rat was 22 g·kg-1.
The prepared concentration was kept in low tempera-
ture (0°C-4°C), and shaken well before use.
Guizhifuling Capsule (Capsule containing Cassia Twig
and Poria): Jiangsu Kangyuan Pharmaceutical Co.,
Ltd. Product batch number: 080305. The medicines in
the capsules were poured out and dissolved in distilled
water to make a final concentration of 0.10 g·mL-1. The
daily dose for one rat was 0.70 g·kg-1.
Mifepristone (Houdingnuo): Zhejiang Xianju Pharma-
ceutical Co., Ltd. Product batch number: 080501. The
drug was dissolved in distilled water to make a final
concentration of 0.94 mg·mL-1. The daily dose for one
rat was 6.25 mg·kg-1.
Modeling and drug administration
Experimental rats were fed normally for a week. After
their adaptation, they were divided into groups accord-
ing to the random number table for model building,
the normal control group (n=10 rats), and the model
group (n=40 rats). Rats from the two groups were
caged separately and allowed to drink water and eat free-
ly. The model group was injected intraperitoneally with
estradiol benzoate(0.5 mg·kg-1), once a day for 25 days in
succession, and then injected intraperitoneally with pro-
gesterone (4 mg·kg-1)once a day for 5 days in succes-
sion. After modeling, the rat models were subdivided
according to the random number table into model con-
trol group, Lichong Decoction group, Guizhifuling
Capsule group, and Mifepristone group. Gavage was
given to the rats in each treatment group, once a day,
and the dosage for each rat was equal to two times of
that for an adult person. The normal and model con-
trol groups were given gavage with an equal amount of
distilled water every day, for 4 weeks in succession. The
rats were weighed once a week. Observations on hair
color and spontaneous activities of rats was monitored.
After drug administration, the rats were made to fast
for 12 h overnight without any limitation on water in-
take, and then weighed. Intraperitoneal anesthesia was
applied with 30% (v/v) chloral hydrate (3 mL·kg-1)
and the uterus of each rat was removed for testing.
Cellular ultrastructure
Uterine tissue 1 cm above the uterine cornu was put in-
to glutaraldehyde liquid, immediately cut into 1 mm3
pieces, fixed, washed with the 2% (v/v) PBS, and em-
bedded for sectioning. Changes in the cellular ultra-
structure of tissue were observed using transmission
electron microscopy.
Expression of IGF-I and PCNA mRNA
Using the real-time PCR, the influence of Lichong De-
coction on the expression of IGF-I and PCNA mRNA
was tested. TIRZOL (1 mL) was added to uterine sam-
ples (50 mg-100 mg) and RNA was extracted. Primers
were designed using Primer Expression 3.0 (Table 1).
Sample RNA was reversely transcribed to cDNA using
the Fermentas K1622 RT-PCR Kit. The reaction con-
637
JTCM |www. journaltcm. com December 15, 2012 |volume 32 | Issue 4 |
Li DH et al. Lichong Decoction on IGF-I and proliferating cell nuclear antigen mRNA in uterine leiomyoma
ditions for real-time PCR amplification and testing
were: 95°C for 5 min; 95°C for 30 s; 53°C for 30 s; 72°C
for 50 s, 40 cycles; 72°C for 8 min. After the reaction,
sample CT values were determined.
Statistical analysis
Data are shown as the mean± standard deviation. The
data were analyzed with SPSS13.0. If data were normal-
ly distributed, a one-way ANOVA was used to analyze
differences among groups. When there was homogenei-
ty of variance, the LSD test was adopted. If not, a Tam-
bane's T2 test was performed. If data were not normal-
ly distributed, the Kruskal-Wallis H test was per-
formed. P<0.05 was regarded as statistically significant.
RESULTS
Transmission electron microscopy
Normal control group: Uterine smooth muscle cells
were in an ordered spindle shape. Around the cells, col-
lagen fibers arranged regularly. The cellular organelles
in the cytoplasm were normal (Figure 1A).
Model control group: Fibroid cells increased in size,
the nucleus increased in volume, and some were ob-
served to be malformed. Cells were rich in actin micro-
filament cables. Mitochondria were hypertrophied and
hyperplasia was evident. The rough endoplasmic reticu-
lum expanded and the number of free ribosomes in-
creased. Around the cells, collagen fibers were hyper-
plastic, disordered, and irregular. These results indicat-
ed that model establishment was successful (Figure 1B).
Lichong Decoction group: Cells appeared ordered, and
organelles were almost normal. The presence of actin
microfilament cables was reduced when compared to
the normal control group. Mitochondria were less hy-
pertrophied. Collagen fibers were arranged relatively
regularly. Hyperplasia was not obvious (Figure 1C).
Guizhifuling Capsule group: Cells were observed to
have slight hyperplasia. The number of cellular organ-
elles decreased. Some mitochondria appeared empty
with bubble-like changes. The rough endoplasmic retic-
ulum appeared to expand, but not to the same extent
as the model control group. Collagen fibers were irregu-
lar and slightly hyperplastic (Figure 1D).
Mifepristone group: Cellular hyperplasia was reduced
and the cell was rich in cellular organelles. There were
some hyperplastic and irregular collagen fibers sur-
rounding cells (Figure 1E).
Influence of Lichong Decoction on the expression of
IGF-I and PCNA mRNA
Amplified PCR products: results: β-actin (264bp),
IGF-I (201bp), and PCNA (231bp) Bands were bright
and visible (Figure 2).
BA C
D E
Figure 1 Transmission electron microscopy
A: The normal control group (×8000)
B: The model control group (×8000)
C: Lichong decoction group (×8000)
D: Guizhifuling group (×8000)
E: Mifepristone group (×8000)
Notes: IGF-I: insulin-like growth factor-I; PCNA:proliferating
cell nuclear antigen.
Table 1 The primer sequences
Gene
β-actin
IGF-I
PCNA
Sequences
up
down
up
down
up
down
5' gagaccttcaacaccccagcc 3'
5' aatgtcacgcacgatttccc 3'
5' acatctcttctacctggcactct 3'
5' aagcaacactcatccacaatg 3'
5' caatttctagcaacgcctaagat3'
5' aagaggaagctgtgtccatagag3'
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IGF-I and PCNA mRNA expression
Compared with the normal control group, the level of
IGF-I and PCNA mRNA expression in the model
group increased significantly (P<0.01). Compared with
the model group, the level of IGF-I and PCNA mRNA
expression in the Lichong Decoction group and Gui-
zhifuling Capsule group decreased significantly (P<
0.01); and the level of IGF-I mRNA expression in the
Mifepristone group decreased significantly (P<0.01),
while PCNA mRNA expression was without statistical
significance (Table 2).
DISCUSSION
Uterine leiomyoma, the incidence of which is rising ev-
ery year, is a commonly seen benign tumor of the fe-
male reproductive organs. It is one of the major rea-
sons for hysterectomies and greatly influences women's
physical and psychological health. The pathogenesis of
uterine leiomyomas is not clear. Modern medicine sug-
gests it is related to environmental factors, gene muta-
tions, progestational hormones, growth factors, and
changes in the extracellular matrix.5-7 Modern medical
treatments include surgery and hormone therapy. How-
ever, these treatments have a great influence on a wom-
an's quality of life and have side effects, so most suffer-
ers refuse to use them. Traditional Chinese Medicine
has its own unique advantages in treating early-stage
uterine leiomyomas, including good outcomes and few
side effects. Therefore, it is necessary to investigate the
effect of Traditional Chinese Medicine on uterine leio-
myomas.
Uterine leiomyoma falls into the category of an "ab-
dominal mass" in TCM according to its clinical mani-
festations. Jing-yue Quan Shu and Fu Ren Gui (The
Complete Works of Jingyue Zhang– Woman Rules)
state that "Long-term stasis developing into lumps is
only a symptom observed in women. The symptoms
may appear during menstruation or postpartum be-
cause of raw or cold food, invasion of cold, or anger
damaging the liver, thus, Qi stagnation results in blood
stasis; or long-term worries damage the spleen, leading
to Qi deficiency, thus, causing blood stasis; or extreme
physical weakness from exhaustion causes Qi deficien-
cy, thus, causing blood stasis. The tumor is the final
presentation of blood stasis". This statement points out
that "deficiency" and "blood stasis" are the basic patho-
genesis of uterine leiomyoma.
Jiaozhu Furen Liangfang (Collated and Annotated Ef-
fective Prescriptions for Women) states: "In general,
dyspepsia and lumps are usually caused by excess patho-
gens during duration of deficiency in anti-pathogenic
Qi. Reinforcing the anti-pathogenic Qi and removing
excess pathogens makes the lumps dissolve automatical-
ly." Reinforcing the anti-pathogenic Qi to remove the
excess pathogens, that is blood stasis, is the treating
principle for uterine leiomyoma.
Lichong Decoction from the Records of Traditional
Chinese and Western Medicine in Combination writ-
ten by the famous doctor Xichun Zhang in the Qing
Dynasty advocates reinforcing anti-pathogenic Qi to re-
move blood stasis, which both strengthens and elimi-
β-actin (264bp)
IGF-I (201bp)
PCNA (231bp)
1 2 3 4 5 6 7 8 9 10 11
Figure 2 Amplified PCR products
IGF-I: insulin-like growth factor-I; PCNA:prolifer-
ating cell nuclear antigen; From left to right: 1,
Marker; 2 and 3, Model control group; 4 and 5,
Lichong Decoction group; 6 and 7, Guizhi Ful-
ing group; 8 and 9, Mifepristone group; 10 and
11, Normal control group.
Table 2 IGF-I and PCNAmRNA expression in each group
(n=10, xˉ ±s)
Group
Normal control
Model
Li Chong Decoction
Guizhi Fuling Capsule
Mifepristone
IGF-I
0.54±0.06a
1.06±0.08
0.69±0.04a
0.68±0.05a
0.78±0.06a
PCNA
0.28±0.05a
0.68±0.06
0.32±0.07a
0.39±0.04a
0.72±0.07
Notes: IGF-I: insulin-like growth factor-I; PCNA:proliferating
cell nuclear antigen; Compared to model group, aP<0.01.
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nates at the same time. In the prescription, raw
Huangqi (Radix Astragali seu Hedysari), Dangshen
(Radix Codonopsis Pilosulae), Baizhu (Rhizoma Atrac-
tylodis Macrocephalae), and raw Shanyao (Rhizoma
Dioscoreae) function to reinforce Qi and strengthen
the spleen; Sanleng (Rhizoma Sparganii), Ezhu (Rhi-
zoma Zedoariae), and raw Jineinin (Endothelium Cor-
neum Gigeriae Galli) are effective in dissolving lumps;
Tianhuafen (Radix Trichosanthis) is used to replenish
Yin and remove toxins; and Zhimu (Rhizoma Anemar-
rhenae) acts to cool the heat of Huangqi and Dang
shen and supplement the kidney with water. Collective-
ly, this prescription functions to reinforce Qi without
disturbing the removal of stasis, and eliminates patho-
gens without damaging anti-pathogenic Qi.
During our early studies, we examined the effect of Li-
chong Decoction on the expression of related genes that
control the death of cells and found that it could induce
the death of myoma cells.3 In order to further study the
functions of Lichong Decoction, we monitored its ef-
fect on IGF-I and PCNA mRNA expression to under-
stand its mechanism of action at the molecular level.
The complex pathogenesis of uterine fibroids is related
to the abnormal expression of proliferation-related
genes of uterine smooth muscle cells. IGF-I, contain-
ing 70 amino acids, is a peptide that has cell differentia-
tion and proliferation functions, and insulin-like metab-
olism.This peptide has intense mitotic activity in normal
cells and tumor cells.9,10 IGF-I is also a common growth
factor in the endocrine, paracrine, and autocrine sys-
tems, and regulates the proliferation and apoptosis in
target organs to stimulate the growth of normal and tu-
mor cells. Studies have shown that IGF-I can promote
the mitosis of cells, and stimulate specifically the prolif-
eration of uterine smooth muscles, thus, being closely as-
sociated with the development of uterine leiomyoma.11,12
PCNA is a coenzyme of DNA polymerase that is di-
rectly involved in the synthesis of DNA in the nucleus
and is closely related to cell proliferative activity. PC-
NA is a highly sensitive and accurate indicator of cell
proliferation.13,14 PCNA is only synthesized and ex-
pressed in proliferating cells. Its synthesis reaches a
peak in the S phase of the cell cycle, while in the G/M
phase it decreases, so its content reflects cell prolifera-
tive activity.15
The results of this study show that compared with the
normal control group, the level of IGF-I and PCNA
mRNA expression in the model group increased signifi-
cantly (P<0.01), indicating that high expression of
IGF-I and PCNA mRNA is the molecular basis of uter-
ine leiomyoma. When comparing the Lichong Decoc-
tion group with the model control group, our findings
revealed that IGF-I and PCNA mRNA expression de-
creased significantly (P<0.01). After the treatment with
Lichong Decoction, ultrastructural observations follow-
ing transmission electron microscopy revealed that cells
were arranged normally, cellular organelles were almost
normal, actin microfilaments were reduced, mitochon-
dria were less hypertrophied, and hyperplasia was not
obvious. These results indicate that Lichong Decoction
was effective on uterine leiomyoma, the mechanism of
which is related to the reduction of IGF-I and PCNA
mRNA expression. Further studies are needed to reveal
the molecular mechanisms of Lichong Decoction in
uterine leiomyomas.
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